tiprankstipranks
Trending News
More News >
Travere Therapeutics (TVTX)
NASDAQ:TVTX
US Market

Travere Therapeutics (TVTX) Income Statement

Compare
545 Followers

Travere Therapeutics Income Statement

Last quarter (Q3 2025), Travere Therapeutics's total revenue was $164.86M, an increase of 162.11% from the same quarter last year. In Q3, Travere Therapeutics's net income was $25.71M. See Travere Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 233.18M$ 145.24M$ 109.46M$ 131.84M$ 198.32M
Gross Profit
$ 225.43M$ 133.79M$ 105.04M$ 128.02M$ 192.19M
Operating Expenses
$ 549.26M$ 521.93M$ 424.85M$ 327.44M$ 368.36M
Depreciation and Amortization
$ 43.55M$ 38.53M$ 20.72M$ 12.75M$ 24.58M
EBITDA
$ -265.77M$ -326.25M$ -299.42M$ -184.46M$ -145.16M
Operating Income
$ -323.83M$ -388.14M$ -319.81M$ -199.43M$ -176.16M
Other Income/Expenses
$ 3.32M$ 12.03M$ -11.34M$ -17.46M$ -12.63M
Pretax Income
$ -320.51M$ -376.11M$ -331.15M$ -216.88M$ -188.79M
Net Income
$ -321.55M$ -111.40M$ -278.48M$ -180.09M$ -169.43M
Per Share Metrics
Basic EPS
$ -4.08$ -1.50$ -4.37$ -3.01$ -3.56
Diluted EPS
$ -4.08$ -1.50$ -4.37$ -3.01$ -3.56
Weighted Average Shares Outstanding
78.89M 74.27M 63.76M 59.83M 47.54M
Weighted Average Shares Outstanding (Diluted)
78.89M 74.27M 63.76M 59.83M 47.54M
Currency in USD

Travere Therapeutics Earnings and Revenue History